|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Reduced expression of DNA topoisomerase I in SF295 human glioblastoma cells selected for resistance to homocamptothecin and diflomotecan显示文摘 | Liao Z Robey R W Guirouilh-Barbat J | 2008 | Mol Pharmaco12008，73，2： | 1 |
| 2 | 查看详情显示文摘 | Landen O L Boehly T R Bradley D K Braun D G Callahan D A Celliers P M Collins G W Dewald E L Divol L Glenzer S H Hamza A Hicks D G Hoffman N Izumi N Jones O S Kirkwood R K Kyrala G A Michel P Milovich J Munro D H Nikroo A Olson R E Robey H F Spears B K Th | | 0，，： | 1 |
| 3 | ABCG2:structure,function and role in drug response显示文摘 | POLGAR O ROBEY R W BATES S E | 2008 | Expert Opin Drug Metab Toxicol2008，4，1： | 1 |
| 4 | Characteris- tics of the low electron density surface layer on BaTiO3 thin films显示文摘 | Hudson L T Kurtz R L Robey S W | 1993 | Phys Rev B1993，47，3： | 1 |
| 5 | Side population analysis using a violet-excited cell-permeable DNA binding dye显示文摘 | Telford W G Bradford J Godfrey W Robey R W Bates S E | 2007 | Stem Cells2007，25，： | 1 |
| 6 | Surface protein characterization of human adipose tissue-derived stromal cells显示文摘 | Gronthos S Franklin D M Leddy H A Robey P G, Storms R W, Gimble J M | | 0，，： | 1 |
| 7 | Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2显示文摘 | TO K K ROBEY R W KNUTSEN T | | 0，，10： | 1 |
| 8 | ABCG2-mediated transport of photosensitizers:potential impact on photodynamic therapy显示文摘 | Robey R W Steadman K Polgar O | 2005 | Cancer Biol Ther2005，4，2： | 1 |
| 9 | Overexpression of the ATP-binding cassette half-transporter,ABCG2(Mxr/BCrp/ABCP1),in flavopiridol-resistant human breast cancer cells 显示文摘 | Robey R W Medina-Perez W Y Nishiyama K | 2001 | Clin Cancer Res2001，7，1： | 1 |
| 10 | ABCG2: structure, function and role in drug response显示文摘 | POLGAR O ROBEY R W BATES S E | 2008 | Expert Opin Drug Metab Toxicol2008，4，1： | 1 |
| 11 | ABCG2: a perspective 显示文摘 | Robey R W To K K Polgar O | 2009 | Adv Drug Deliv Rev2009，61，1： | 1 |
| 12 | Single nucleotide polymorphisms modify the transporter activity of ABCG2显示文摘 | MORISAKI K ROBEY R W OZVEGY-LACZKA C ef al | 2005 | Cancer Chemother Pharmacol2005，56，2： | 1 |
| 13 | Synthesis of dapoxetine·HCl, a serotonin re-uptake inhibitor: biodistribution in rat and preliminary PET imaging in the monkey显示文摘 | LIVNI E SATTERLEE W ROBEY R L | 1994 | Nucl Med Biol1994，21，4： | 1 |
| 14 | ABCG2: per- spective显示文摘 | Robey R W To K K Polgar O | 2009 | Adv Drug Deliv Rev2009，61，1： | 1 |
| 15 | Overexpression of the ATP-binding cassette half-transporter ABCG2 ( MXR/ BCRP/ABCP1 ), in flavopiridol-resistant human breast cancer ceils 显示文摘 | Robey R W Medina-Perez W Y Nishiyama K | 2001 | Clin Cancer Res2001，7，： | 1 |
| 16 | Sunitinib (Sutent, SUl1248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P glycoprotein (ABCB1) and ABCG2显示文摘 | Shukla S Robey R W Bates S E | 2009 | Drug Metab Dispos2009，37，2： | 1 |
| 17 | T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance 显示文摘 | Piekarz R L Robey R W Zhan Z | 2004 | Blood2004，103，12： | 1 |
| 18 | ABCG2:a perspective显示文摘 | ROBEY R W TO K K POLGAR O | 2009 | Adv Drug Deliv Rev2009，61，1： | 1 |
| 19 | ABCG2:a perspective显示文摘 | Robey R W To K K Polgar O | 2009 | Adv Drug Deliv Rev2009，61，1： | 1 |
| 20 | Chemoresistance in the clinic:Overview 1994显示文摘 | Bates S E Regis J I Robey R W | 1994 | Bull Cancer1994，81，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员